A previous study by Tabeling et al. [26] indicated that the endothelin B receptor (ETBR) has an anti-inflammatory effect on the pathology of PAH, and ETBR deficiency may be associated with perivascular inflammation in the lungs. The gene discussed is EDNRB; the disease is pulmonary arterial hypertension.